OTC · Financial Statements
Anthera Pharmaceuticals, Inc. (ANTH) Financial Statements
$0.00
OTC: ANTH
Market Cap $2618
Overview Financials Dividend Anthera Pharmaceuticals, Inc. most recently reported annual revenue of $0, net profit of $-17.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2013 2014 2015 2016 2017 Revenue $0 $0 $3.0M $0 $0 Operating Profit $-28.0M $-28.0M $-35.0M $-57.0M $-36.0M Net Profit $-33.0M $-30.0M $-35.0M $-54.0M $-17.0M EPS $-14.50 $-11.13 $-7.84 $-10.38 $-1.65 Op Margin — — -1106.5% -39432.4% —
Balance Sheet (USD)
Metric 2013 2014 2015 2016 2017 Total Assets $37.0M $3.0M $48.0M $23.0M $4.0M Total Liabilities $23.0M $6.0M $8.0M $11.0M $9.0M Cash $26.0M $3.0M $47.0M $21.0M $2.0M Borrowings $18.0M $0 $0 $0 $0
Cash Flow (USD)
Metric 2013 2014 2015 2016 2017 Operating Cash Flow $-32.0M $-26.0M $-31.0M $-49.0M $-37.0M Investing Cash Flow $-5.0M $10.0M $0 $-2.0M $0 Financing Cash Flow $0 $0 $0 $24.0M $0 Net Cash Flow $7.0M $-23.0M $44.0M $-26.0M $-19.0M Free Cash Flow $-32.0M $-26.0M $-31.0M $-50.0M $-37.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.08 FCF Yield -1409472.88% Quick Ratio 0.68 Interest Coverage 0.00 Return 1Y 0.00% Return 3Y 0.00% Return 5Y —
Screens featuring this stock